 |
 |
WESTPORT, May 20 (Reuters) - Amantadine, a drug used for decades to treat the early stages of Parkinson's disease, appears to reduce dyskinesias and motor fluctuations in late-stage disease when given as an adjuvant to levodopa. "This discovery is exciting," Dr. Thomas L. Chase of the National Institute of Neurological Disorders & Stroke in Bethesda, Maryland, explains in a statement from the Institute, "...because surgery was the only option to treat dyskinesias and motor fluctuations...and is not an effective treatment for all patients." For details, go to ... http://ipn.intelihealth.com/ipn/ihtIPN?c=187792 _ -- Kathrynne Holden, MS, RD "Nutrition you can live with!" Medical nutrition therapy http://www.nutritionucanlivewith.com/ Tel: 970-493-6532 // Fax: 970-493-6538